Complement Therapeutics
Clinical trials sponsored by Complement Therapeutics, explained in plain language.
-
One-Shot eye injection aims to halt blinding disease
Disease control Recruiting nowThis study is testing a new, one-time injection called CTx001 for people with geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. The main goals are to see if the injection is safe and if it can slow down the damage to the reti…
Phase: PHASE1, PHASE2 • Sponsor: Complement Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Scientists watch closely as eye disease steals sight
Knowledge-focused Recruiting nowThis is an observational study that aims to learn more about how quickly geographic atrophy, a form of age-related macular degeneration that causes permanent vision loss, gets worse over a short period. It will enroll about 75 people aged 55 and older who have this condition in b…
Sponsor: Complement Therapeutics • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC